BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10613588)

  • 1. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
    Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of prenephrectomy CD profiles and serum cytokines to the disease outcome and response to IFN-alpha/IL-2 therapy in renal cell carcinoma patients.
    Lauerová L; Dusek L; Spurny V; Simicková M; Rovny A; Rejthar A; Kocák I; Kovarík J
    Oncol Rep; 2001; 8(3):685-92. PubMed ID: 11295103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the relationship between the level of cytokine and liver function in patients with clonorchiasis sinensis].
    Cai LS; Xiao JY; Xin H; Zhu LX; Chen G; Zhang T; Wang GZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Feb; 22(1):54-6. PubMed ID: 15283270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
    Czelej D; Chodorowska G; Lechowska-Mazur I
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):38-42. PubMed ID: 15314956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
    Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
    Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
    Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytokines and soluble cytokine receptors in the perioperative period].
    Maruna P; Gürlich R; Frasko R; Chachkhiani I; Marunová M; Owen K; Pesková M
    Sb Lek; 2002; 103(2):273-82. PubMed ID: 12688152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis.
    Madson KL; Moore TL; Lawrence JM; Osborn TG
    J Rheumatol; 1994 Dec; 21(12):2359-63. PubMed ID: 7699643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma.
    Chodorowska G; Czelej D
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytokines in children with immunodeficiencies].
    Kowalczyk D
    Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
    Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].
    Tang L; Luo Q; Zhou X; Xia R
    Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):165-7. PubMed ID: 11955323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.
    Baykal Y; Saglam K; Yilmaz MI; Taslipinar A; Akinci SB; Inal A
    Clin Rheumatol; 2003 May; 22(2):99-101. PubMed ID: 12740672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
    Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF alpha, IL-1 beta and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma.
    Ikemoto S; Sugimura K; Yoshida N; Wada S; Yamamoto K; Kishimoto T
    Anticancer Res; 2000; 20(1A):317-21. PubMed ID: 10769674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.